• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含甘油腹膜透析液对体内腹膜巨噬细胞功能的影响。

The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.

作者信息

de Fijter C W, Verbrugh H A, Oe P L, Peters E D, van der Meulen J, Donker A J, Verhoef J, Lameire N

机构信息

Department of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands.

出版信息

Adv Perit Dial. 1991;7:154-7.

PMID:1680414
Abstract

Though glucose is universally applied as osmotic agent in CAPD, there is great interest in the use of alternative osmotic agents. Glycerol-containing peritoneal dialysis fluids (G-PDF) have been used in an attempt to minimize the metabolic effects of long-term exposure to glucose, especially in patients with diabetes. Since data were lacking, we studied the effect of G-PDF on peritoneal macrophage (PMO) function. In a randomized cross-over setting eight stable diabetic CAPD patients performed the third and fourth exchange of the day with either G-PDF or with glucose-containing PDF (D-PDF) of comparable osmolality. The next day the patients who had used G-PDF were switched to D-PDF and vice versa. PMO were isolated from the effluents and tested for their phagocytic capacity and chemiluminescence response. No differences were encountered in total and differential white cell counts between G-PDF and D-PDF effluents. PMO phagocytic capacity for both S. epidermidis (SE) and E. coli (EC) was significantly depressed after the instillation of G-PDF as compared to D-PDF (SE: 52 +/- 2.7 vs 69 +/- 5.0%, p less than 0.02, and EC: 44 +/- 5.7 vs 63 +/- 6.7%, p less than 0.02). The same held true for peak chemiluminescence response (5.3 +/- 1.36 vs 7.2 +/- 1.43% of control cells, p less than 0.005). Thus, G-PDF may compromise PMO function in vivo more than D-PDF despite its more favourable metabolic profile as compared to D-PDF for diabetic patients.

摘要

尽管葡萄糖在持续性非卧床腹膜透析(CAPD)中被普遍用作渗透剂,但人们对使用替代渗透剂仍有着浓厚兴趣。含甘油的腹膜透析液(G-PDF)已被用于尽量减少长期接触葡萄糖所产生的代谢影响,尤其是在糖尿病患者中。由于缺乏相关数据,我们研究了G-PDF对腹膜巨噬细胞(PMO)功能的影响。在一项随机交叉试验中,八名病情稳定的糖尿病CAPD患者使用渗透压相当的G-PDF或含葡萄糖的腹膜透析液(D-PDF)进行当日的第三次和第四次换液。第二天,使用G-PDF的患者改用D-PDF,反之亦然。从流出液中分离出PMO,并检测其吞噬能力和化学发光反应。G-PDF和D-PDF流出液的白细胞总数和分类计数没有差异。与D-PDF相比,灌注G-PDF后,PMO对表皮葡萄球菌(SE)和大肠杆菌(EC)的吞噬能力均显著降低(SE:52±2.7%对69±5.0%,p<0.02;EC:44±5.7%对63±6.7%,p<0.02)。化学发光峰值反应也是如此(为对照细胞的5.3±1.36%对7.2±1.43%,p<0.005)。因此,尽管与D-PDF相比,G-PDF对糖尿病患者的代谢状况更为有利,但它在体内对PMO功能的损害可能比D-PDF更大。

相似文献

1
The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.含甘油腹膜透析液对体内腹膜巨噬细胞功能的影响。
Adv Perit Dial. 1991;7:154-7.
2
In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
Clin Nephrol. 1993 Feb;39(2):75-80.
3
Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.限制使用基于葡萄糖的高渗腹膜透析液的另一个原因:其对体内腹膜巨噬细胞功能的影响。
Adv Perit Dial. 1991;7:150-3.
4
Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.含1.1%氨基酸的腹膜透析液与含2.27%葡萄糖的腹膜透析液的生物相容性比较。
Nephron. 1996;74(1):26-32. doi: 10.1159/000189277.
5
In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function.含1.1%氨基酸的腹膜透析液与吞噬细胞功能的体外相容性
Adv Perit Dial. 1994;10:241-4.
6
Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?自动化腹膜透析中的抗菌腹膜防御:潮式腹膜透析相对于持续循环腹膜透析的优势?
Nephrol Dial Transplant. 1994;9(2):156-62.
7
In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
Nephron. 1994;68(3):338-46. doi: 10.1159/000188397.
8
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.腹膜透析液(PDF)中的C++和1,25(OH)2D3调节持续性非卧床腹膜透析(CAPD)患者腹膜巨噬细胞(PM0)的抗菌活性。
Adv Perit Dial. 1990;6:110-3.
9
Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S97-103.
10
Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?对于与持续性非卧床腹膜透析(CAPD)相关的腹膜炎,细胞内穿透性抗生素是否适用?
Adv Perit Dial. 1989;5:124-7.

引用本文的文献

1
Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis.在伴有和不伴有腹膜硬化的患者中使用非葡萄糖透析液治疗严重超滤失败。
NDT Plus. 2008 Oct;1(Suppl 4):iv63-iv70. doi: 10.1093/ndtplus/sfn127.